CANbridge Pharmaceuticals Inc. (1228.HK)
HKD 0.16
(0.65%)
HKD 0.16
(0.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -278.23 Million | -280.97 Million | -587.07 Million | -151.64 Million | -126.17 Million |
| Net Income | -378.83 Million | -483.47 Million | -1.07 Billion | -846.04 Million | -217.67 Million |
| Depreciation & Amortization | 28.46 Million | 21.97 Million | 15.7 Million | 17.83 Million | 3.59 Million |
| Deferred income taxes | - | 33.56 Million | -42.2 Million | 23.29 Million | 3.55 Million |
| Stock-based compensation | 19.91 Million | 26.82 Million | 30.51 Million | 14.65 Million | 16.69 Million |
| Change in working capital | 28.08 Million | 118.94 Million | 23.01 Million | 45.99 Million | -9.73 Million |
| Other non-cash items | -2.02 Million | 1.18 Million | 462.9 Million | 592.6 Million | 77.39 Million |
| Investing Cash Flow | -26.85 Million | -34.78 Million | 126.09 Million | -153.48 Million | -42.42 Million |
| Investments in PPE | -40.86 Million | -34.78 Million | -5.33 Million | -153.48 Million | -42.47 Million |
| Acquisitions | - | - | - | - | 41.39 Million |
| Investment purchases | - | - | - | - | -12 Million |
| Sales/Maturities of investments | - | - | - | - | 12 Million |
| Other Investing Activities | 14 Million | -19.58 Million | 131.42 Million | -150.91 Million | -41.34 Million |
| Financing Cash Flow | -28.01 Million | -20.7 Million | 854.31 Million | 679.26 Million | 96.96 Million |
| Debt repayment | -7.75 Million | -34 Million | -24.5 Million | -14.24 Million | -1 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 76 Thousand | 34 Thousand | 563.8 Million | 985 Thousand | - |
| Other Financing Activities | -640 Thousand | 13.26 Million | 315.01 Million | 692.52 Million | 97.96 Million |
| Accounts receivables | -12.17 Million | -9.91 Million | -2.1 Million | -6.6 Million | -193 Thousand |
| Accounts payables | - | 9.91 Million | 2.1 Million | 6.6 Million | 193 Thousand |
| Inventory | 1.04 Million | 3.62 Million | -12.89 Million | 66 Thousand | -3.02 Million |
| Other working capital | -51.3 Million | 115.32 Million | 35.91 Million | 45.93 Million | -6.71 Million |
| Cash at beginning of period | 451.15 Million | 745.81 Million | 360.8 Million | 13.87 Million | 85.24 Million |
| Cash at end of period | 124.9 Million | 451.15 Million | 745.81 Million | 360.8 Million | 13.87 Million |
| Capital Expenditure | -40.86 Million | -34.78 Million | -5.33 Million | -153.48 Million | -42.47 Million |
| Effect of forex changes on cash | 6.84 Million | 41.81 Million | -8.32 Million | -27.2 Million | 261 Thousand |
| Net cash flow / Change in cash | -326.25 Million | -294.65 Million | 385.01 Million | 346.93 Million | -71.36 Million |
| Free Cash Flow | -319.09 Million | -315.76 Million | -592.4 Million | -305.13 Million | -168.65 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -123.63 Million | -123.63 Million | -80.33 Million | -378.83 Million | -80.33 Million | -109.08 Million |
| Depreciation & Amortization | 6.85 Million | 6.85 Million | 7.38 Million | 28.46 Million | 7.32 Million | 6.84 Million |
| Deferred income taxes | - | - | - | - | - | 1.83 Million |
| Stock-based compensation | 2.37 Million | 2.37 Million | 3.09 Million | 19.91 Million | 3.09 Million | 6.86 Million |
| Change in working capital | -8.61 Million | -8.61 Million | 2.27 Million | 28.08 Million | 2.27 Million | -33.49 Million |
| Other non-cash items | 68.86 Million | 68.86 Million | 13.46 Million | -2.02 Million | 13.52 Million | 43.87 Million |
| Investing Cash Flow | 7 Million | 7 Million | -11.73 Million | -26.85 Million | -11.73 Million | -1.69 Million |
| Investments in PPE | -7000.00 | -7000.00 | -927 Thousand | -40.86 Million | -927 Thousand | -1.64 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 7 Million | 7 Million | -10.8 Million | 14 Million | -10.8 Million | -50.5 Thousand |
| Financing Cash Flow | 5.95 Million | 5.95 Million | -6.54 Million | -28.01 Million | -6.54 Million | -7.46 Million |
| Debt repayment | - | - | - | -7.75 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 76 Thousand | - | - |
| Other Financing Activities | 5.95 Million | 5.95 Million | -6.54 Million | -640 Thousand | -6.54 Million | -7.46 Million |
| Accounts receivables | 1.38 Million | 1.38 Million | -2.42 Million | -12.17 Million | -2.42 Million | -3.66 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -1.97 Million | -1.97 Million | 5.55 Million | 1.04 Million | 5.55 Million | -5.02 Million |
| Other working capital | -8.02 Million | -8.02 Million | -852.5 Thousand | -51.3 Million | -852.5 Thousand | -24.79 Million |
| Cash at beginning of period | - | - | - | 451.15 Million | - | - |
| Cash at end of period | -40.99 Million | -40.99 Million | -73.12 Million | 124.9 Million | -73.12 Million | -89.99 Million |
| Capital Expenditure | -7000.00 | -7000.00 | -927 Thousand | -40.86 Million | -927 Thousand | -1.64 Million |
| Effect of forex changes on cash | 198 Thousand | 198 Thousand | -739.5 Thousand | 6.84 Million | -739.5 Thousand | 4.16 Million |
| Net cash flow / Change in cash | -40.99 Million | -40.99 Million | -73.12 Million | -326.25 Million | -73.12 Million | -89.99 Million |
| Free Cash Flow | -54.15 Million | -54.15 Million | -55.04 Million | -319.09 Million | -55.04 Million | -86.64 Million |
THG
MGIDF
MQ
0JQZ
ERA
HLLGY